
Respiratory Drugs
Prescription drugs and medicines for conditions and diseases relating to the lungs and/or breathing. Studies in these areas include: Acute Respiratory Distress Syndrome (ARDS), allergy, asthma, bronchitis, cystic fibrosis, emphysema, lung disease, pneumonia, sinus infections, smoking cessation, and others.
The list of FDA approved drugs for respiratory and pulmonary conditions appears below. Click any link to view the full drug information.
Number Of Respiratory Drugs: 96
For the treatment of non-small cell lung cancer
zafirlukast, 10 mg and 20 mg tablets.
Treatment for asthma
For the treatment of pulmonary arterial hypertension
For the treatment of Mucopolysaccharidosis I (MPS I) in subjects aged 5 to 65
Treatment for seasonal allergy symptoms
Treatment for nasal congestion due to seasonal allergy
For the maintenance treatment of asthma as prophylactic therapy in adults and adolescents
For the treatment of airflow obstruction resulting from chronic obstructive pulmonary disease
Treatment for seasonal allergic rhinitis
Treatment for runny nose due to allergies and the common cold
Treatment for infections involving drug-resistant bacteria
Injectable antibacterial agent for adults with susceptible strains of bacterial infections
Treatment for asthma
For Acute Bacterial Exacerbation of Chronic Bronchitis (AECB) and Acute Maxillary Sinusitis
Treatment for breathing difficulties due to deviated nasal septum
For the treatment of Chronic Obstructive Pulmonary Disease
For the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age.
For the treatment of cystic fibrosis patients with Pseudomonas aeruginosa
Treatment for chronic bronchitis, acute bacterial otitis media, pharyngitis/tonsillitis
Respiratory tract infections
Treatment of secondary bacterial infections of acute bronchitis
Treatment for acute sinusitis
Once-daily oral tablet for the treatment of allergic rhinitis and chronic ideopathic urticaria
Treatment for seasonal allergy symptoms
Treatment for children with seasonal allergies
Treatment for nasal congestion
Generic equivalent of Tavist Syrup
Treatment for hypertension and angina
Treatment for respiratory distress syndrome in premature infants.
For the treatment of chronic obstructive pulmonary disease
For the treatment of asthma
For the treatment of bronchospasm associated with COPD
For the relief of symptoms of seasonal allergic rhinitis
Treatment for acute bacterial exacerbations (chronic bronchitis and skin infections)
Treatment for seasonal and perennial allergic rhinitis
Treatment of asthma in patients four and older
Bronchodilator for COPD, asthma and bronchospasm
For the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants
Once-daily injectable treatment for bacterial infections
For the second-line treatment of non-small-cell lung cancer
For the treatment of cystic fibrosis with the G551D mutation in the CFTR gene
For the treatment of infections caused by bronchitis, bacterial sinusitis and Community-acquired pneumonia.
For the treatment of pulmonary arterial hypertension
Generic equivalent of Alupentr Inhalation Solution, 5%
Treatment of nasal symptoms of seasonal allergic rhinitis in children Aged 6-11
Treatment for allergic rhinitis
Over-the-counter nasal spray for treatment of all nasal allergy symptoms
Over-the-counter antihistamine eye drop
Treatment against various bacterias
For the treatment of seasonal allergic rhinitis
Treatment for pulmonary tuberculosis
Treatment or prevention of bronchospasm
Treatment for cystic fibrosis
Treatment for cystic fibrosis patients with advanced disease
For the treatment of seasonal and perennial allergic rhinitis
For the treatment of asthma
Treatment for chronic bronchitis
For the treatment of certain inflammatory diseases, including arthritis, COPD, asthma and psoriatic conditions
For the treatment of pulmonary arterial hypertension in patients with NYHA Class II-IV symptoms
Treatment for the prevention of respiratory syncytial virus disease
A nasal spray containing budesonide
Treatment for malignant pleural effusions
Treatment of asthma
Treatment for asthma
For the treatment of bronchospasm associated with chronic obstructive pulmonary disease
For the treatment of respiratory distress syndrome in premature infants
Treatment for the prevention of serious lower respiratory tract disease in infants
Treatment for cold symptoms
Oral tablet for temporary relief of symptoms associated with hay fever, allergic rhinitis, and the common cold
For the treatment of bacterial skin infections and bacterial pneumonia
Tequin (Injectable and Tablet)
Capsules of dofetilide
Treatment for asthma
Treatment for mild to moderate asthma
Treatment for mild-to-moderate bronchial asthma
Treatment for cystic fibrosis
For the treatment of pulmonary arterial hypertension
For treatment of nasal symptoms of allergic rhinitis in adults and children age 12 or older
Treatment for whooping cough
For the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease
For the treatment of complicated skin and skin structure and intra-abdominal infections and bacterial pneumonia
For the treatment of pulmonary arterial hypertension
Treatment for allergic and non-allergic rhinitis
Treatment for asthma
For the treatment or prevention of bronchospasm
Diagnostic contrast agent
For the treatment of ALK+ non-small cell lung cancer
For the treatment of asthma
Inhaled solution for treatment of reversible obstructive airway disease
For the treatment of seasonal and perennial allergic rhinitis and urticaria
Treatment for community-acquired pneumonia (CAP) and chronic bronchitis
For the treatment of alpha1-proteinase inhibitor deficiency (Alpha-1) and emphysema
Treatment for hospital-acquired pneumonia
Treatment for asthma in patients 12 years and older
Treatment for year-round allergies, seasonal allergic rhinitis, and chronic itching and hives
FDA Approved Respiratory Drugs Listings:
The rules of principle for evaluating MediLexicon's FDA respiratory drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
The respiratory drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.



